tiprankstipranks
Charles River acquires SAMDI Tech for $50M cash
The Fly

Charles River acquires SAMDI Tech for $50M cash

Charles River Laboratories International announced that it has acquired SAMDI Tech provider of label-free high-throughput screening HTS solutions for drug discovery research. The acquisition marks the culmination of a partnership between the companies that began in 2018. Based in Chicago, Illinois, SAMDI Tech offers a proprietary mass spectrometry MS technology for high-throughput analysis of biochemical activities and affinity selection MS SAMDI ASMS for identifying binding interactions. The technology minimizes false positive results, reduces reagent requirements, and offers multiplexing capabilities without restricting assay conditions. These solutions are increasingly favored by clients to accelerate the timeline and reduce costs to identify a lead drug candidate, drive more effective research and high-quality scientific data, and enable clients to make critical go-no-go decisions earlier and advance their projects more efficiently. SAMDI Tech’s comprehensive drug discovery solutions also include optical and radioactivity capabilities, cell-based assays, and an in-house collection of over a half million drug-like small molecules. James C. Foster, Chairman, President and Chief Executive Officer of Charles River Laboratories, commented, "The acquisition of SAMDI Tech’s cutting-edge, high-throughput screening technology further strengthens Charles River’s drug discovery capabilities and enhances our unique ability to serve as an integrated partner to support our clients’ early-stage research. SAMDI Tech’s platform combined with our premier, end-to-end drug discovery portfolio will generate better data and faster hit identification and is another step to accelerate our clients’ drug discovery efforts. With over a decade of industry experience and the successful, existing partnership, we believe the addition of SAMDI Tech will continue to generate new business opportunities and we are pleased to welcome them to the Charles River family." The purchase price was $50M in cash for the remaining 80% ownership stake in SAMDI Tech that Charles River did not already own, subject to customary post-closing adjustments. Additional financial details were not disclosed as the transaction is not expected to have a material impact on Charles River’s financial results in 2023. SAMDI Tech will become part of the Company’s Discovery and Safety Assessment segment.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on CRL:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles